摘要
粪菌移植(Fecal microbiota transplantation,FMT)已被美国医学指南、欧洲专家共识推荐用于成人复发性艰难梭菌感染(Clostridium difficileinfection,CDI)。本文主要就FMT治疗CDI的适应证、临床流程、安全性、伦理与监管等的研究进展及中国医生的治疗选择进行综述。
Fecal microbiota transplantation（FMT）has been recommended by American Medical Guideline and European Expert Consensus to treat recurrent Clostridium difficile infection（CDI）.This article aims to review the research advancement of indications,clinical workflow,safety,and ethics of and supervision on FMT in the treatment of CDI and the concerned treatment options of Chinese doctors.
作者
向丽园
张发明
Xiang Liyuan;Zhang Faming(Medical Center for Digestive Diseases,the Second Affiliated Hospital of Nanjing Medical University Nanjing 210011,China;Department of Microbiotherapy,Sir Run Run Hospital at Nanjing Medical University,Nanjing 211166,China)
出处
《临床荟萃》
CAS
2018年第5期385-389,共5页
Clinical Focus
基金
国家自然科学基金(81600417)
江苏省创新团队
肠病研究基金(公益捐赠)
关键词
梭菌感染
移植
粪菌
Clostridium infections
transplantation
fecal microbiota
